These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 17015185
1. High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy. Sugano M, Yamato H, Hayashi T, Ochiai H, Kakuchi J, Goto S, Nishijima F, Iino N, Kazama JJ, Takeuchi T, Mokuda O, Ishikawa T, Okazaki R. Nutr Metab Cardiovasc Dis; 2006 Oct; 16(7):477-84. PubMed ID: 17015185 [Abstract] [Full Text] [Related]
2. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, Reaven GM. Metabolism; 2000 Nov; 49(11):1390-4. PubMed ID: 11092499 [Abstract] [Full Text] [Related]
6. Spontaneous motor activity in fat-fed, streptozotocin-treated rats: a nonobese model of type 2 diabetes. Ramadan W, Dewasmes G, Petitjean M, Loos N, Delanaud S, Geloen A, Libert JP. Physiol Behav; 2006 Apr 15; 87(4):765-72. PubMed ID: 16516253 [Abstract] [Full Text] [Related]
7. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Sahin K, Onderci M, Tuzcu M, Ustundag B, Cikim G, Ozercan IH, Sriramoju V, Juturu V, Komorowski JR. Metabolism; 2007 Sep 15; 56(9):1233-40. PubMed ID: 17697867 [Abstract] [Full Text] [Related]
10. [Expression level of cubilin in the rat model of diabetic nephropathy]. Feng M, Zhang Z, Fu P, Huang SM, Yang YB, Su KL, Chen ZJ, Tang WX. Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep 15; 37(5):738-41. PubMed ID: 17037740 [Abstract] [Full Text] [Related]
11. [Nephro-protective effects of total triterpenoids from Psidium guajava leaves on type 2 diabetic rats]. Kuang QT, Zhao JJ, Ye CL, Wang JR, Ye KH, Zhang XQ, Wang Y, Ye WC. Zhong Yao Cai; 2012 Jan 15; 35(1):94-7. PubMed ID: 22734419 [Abstract] [Full Text] [Related]
12. Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats. Kirino Y, Sato Y, Kamimoto T, Kawazoe K, Minakuchi K, Nakahori Y. J Endocrinol; 2009 Jan 15; 200(1):53-61. PubMed ID: 18931022 [Abstract] [Full Text] [Related]
15. Effects of timely insulin treatment on protection of beta cells in a rat model of type 2 diabetes mellitus. Zhou YS, Gao Y, Guo XH, Li B, Wang S, Chi JM. Chin Med J (Engl); 2004 Oct 15; 117(10):1523-9. PubMed ID: 15498377 [Abstract] [Full Text] [Related]
18. The effects of dietary cholesterol on experimental diabetic nephropathy. Cooper ME, Vranes D, Vranes DA, Allen TJ, Panagiotopoulos S, Komers R, Jerums G. Diabetes Res; 1993 Oct 15; 22(4):159-69. PubMed ID: 8070237 [Abstract] [Full Text] [Related]
19. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy. Mima A, Arai H, Matsubara T, Abe H, Nagai K, Tamura Y, Torikoshi K, Araki M, Kanamori H, Takahashi T, Tominaga T, Matsuura M, Iehara N, Fukatsu A, Kita T, Doi T. Diabetes; 2008 Jun 15; 57(6):1712-22. PubMed ID: 18285555 [Abstract] [Full Text] [Related]
20. [Improvement of the function of islet beta and alpha cells by intervention against glucotoxicity: experiment with rats]. He QH, Zhou YS, Wang Z, Wang S, Mou ZQ, Li J, Chi JM. Zhonghua Yi Xue Za Zhi; 2008 Feb 05; 88(6):374-7. PubMed ID: 18581888 [Abstract] [Full Text] [Related] Page: [Next] [New Search]